Centauri has developed a pipeline of novel therapeutic candidates based on our proprietary Alphamer® platform. Our current focus is on developing novel treatments for infectious diseases, however the Alphamer® platform also has potential strong proof-of-concept data for applications in oncology.
For more information on investment and partnering opportunities, please contact us.
